Illumina, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +1.2%
EBITDA: +402.1%
EBIT: +284.7%
EPS: +191.3%
Free cash flow: +13.8%
Operating cash flow: +12.8%

Forward estimates

Revenue: +5.9%
EBITDA: —
EPS: -0.2%

Three-year CAGR

Revenue: -1.8%
EBITDA: +301.0%
EBIT: +203.7%
Net income: +169.5%
EPS: +171.3%
Free cash flow: +106.3%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.